Capitalized Software Development Costs (Notes)	3 Months Ended
Capitalized Software Development Costs (Notes)	Mar. 31, 2016
Capitalized Software Development Costs Disclosure [Abstract]
Research, Development, and Computer Software Disclosure [Text Block]	Capitalized Software Development Costs In accordance with the relevant authoritative accounting literature the Company has capitalized certain software and product related development costs associated with both the Company’s continuing medical education service offerings, and the Company’s recent development of its property and casualty underwriting insurance data exchange platform. During three months ended March 31, 2016, the Company capitalized $144 thousand of such development costs. As of March 31, 2016, a total of $3.2 million of remaining unamortized development costs are reported on the Company’s consolidated balance sheet. During the three months ended March 31, 2016, the Company recognized $326 thousand of amortization expense with regards to these capitalized software development costs, which is included in costs of services provided in the Company’s consolidated income statement. The useful life over which these capitalized software development costs are being amortized is eighteen months for the continuing medical education products, and six years for the property and casualty underwriting insurance data exchange platform.

The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.